Between OPAT courses, infusion claims, hospital consults, and a payer mix full of prior authorizations, the path from charge to payment is long and easy to derail. A single denied drug claim can erase weeks of acquisition cost before anyone notices.
This article defines cost to collect, walks through a practice-level calculation, breaks down the cost drivers specific to infectious disease, and compares efficient versus inefficient revenue cycle models. We won't hand you an industry benchmark that doesn't exist for this specialty. Instead, you'll get a method for building your own.
Key Takeaways
- Calculate cost to collect as defined RCM expenses divided by defined collections; never compare figures built on different scopes.
- OPAT billing, infusion documentation, drug workflows, and prior authorizations drive costs that general medical billing data miss.
- A low cost-to-collect number isn't automatically good; it can hide understaffing, missed charges, or weak denial follow-up.
- Aim for the lowest sustainable cost that still protects clean claims, compliance, and complete revenue capture.
How Much Does Revenue Cycle Management Cost to Collect?
There's no single price tag for cost to collect, and no universal benchmark that applies cleanly to infectious disease. Practices differ too much in size, staffing model, technology stack, payer mix, and how much billing work happens in-house versus through a vendor.
The core formula, per HFMA's MAP Keys, is straightforward: total revenue-cycle operating expense for a period, divided by net patient-service cash collected for that same period, net of refunds. Decide upfront whether your denominator is gross collections, net collections, or another consistently defined figure, then stick with it.
Where the Math Goes Wrong
Three mistakes show up constantly:
- Understating costs by leaving out physician time, administrator oversight, clearinghouse fees, or technology spend devoted to billing
- Overstating costs by mixing unrelated clinical or administrative expenses into the RCM numerator
- Comparing apples to oranges: stacking an internal cost-to-collect figure against a vendor's percentage-of-collections fee without matching the services and cost categories included
HFMA's cost-to-collect guidance notes that billing-service arrangements often price only the collection activity itself, while retained practice labor, software, and oversight still belong in your total. Compare fully loaded costs, not just the invoice.
Setting a Reporting Period
Run this monthly or quarterly, and watch for distortions: a large payer settlement, a staffing change, seasonal volume swings, or a new EHR rollout can all throw off a single period's number. Look at several periods before drawing conclusions.
A hypothetical illustration: Say a practice spends $45,000 a month on RCM staff, vendor fees, clearinghouse charges, and payment processing, and collects $900,000 in net patient and payer payments that month. That's a 5% cost-to-collect ratio. This is a made-up example to show the math, not a target to aim for.
What counts in that numerator? Typically:
- RCM labor
- Billing or coding vendor fees
- Clearinghouse and software costs
- Payment processing fees
- Credentialing or authorization work
Whether clinical staff time devoted to documentation support belongs there depends on what you're trying to measure.
Key Factors That Affect Cost to Collect and Its Breakdown
Cost to collect isn't just a function of what you pay your billing staff. Operational design, clinical documentation complexity, and payer behavior all push the number up or down.
RCM Staffing and Workflow Design
Every stage of the cycle adds cost: registration, eligibility verification, charge capture, coding, claim submission, payment posting, denial management, and A/R follow-up. Separate dedicated RCM labor from shared staff time before you calculate anything.
| Model | Cost consideration |
|---|---|
| In-house | Full compensation, benefits, software, and management overhead |
| Outsourced | Contract fee plus retained practice labor and oversight |
| Hybrid | Internal costs plus selected purchased services |
| Technology-supported | Software licensing offset against reduced manual labor |
None of these models is inherently cheaper. A low-fee outsourced arrangement that misses denials or delays appeals can cost more in lost revenue than a pricier in-house team that catches problems early.
Infectious Disease Service-Line Complexity
OPAT, infusion, hydration, hospital consults, and transitional care each carry their own documentation, coding, authorization, and follow-up demands.
Drug acquisition, wastage, supplies, and nursing time affect service-line profitability. Keep them out of your cost-to-collect numerator unless you are measuring total service-line economics rather than pure RCM efficiency.
Payer Mix, Contracting, and Administrative Burden
Medicare, Medicare Advantage, Medicaid, commercial plans, and self-pay accounts each bring different authorization, filing, and appeal workloads. Segment your results by payer and service line: a blended, practice-wide figure can easily hide one expensive payer relationship or an underperforming contract.
Claims Quality, Denials, and A/R Age
Coding errors, missing medical necessity documentation, incomplete infusion start/stop times, invalid authorizations, and modifier mistakes all create rework, and rework raises cost to collect. Don't treat this metric as a standalone scorecard. Pair it with:
- Denial rate and first-pass acceptance rate
- Days in A/R and aging distribution
- Write-offs and appeal yield
- Net collection rate
One-Time and Recurring Costs
Separate the steady costs (salaries, vendor fees, software, clearinghouse charges) from the periodic ones, like a system migration, workflow redesign, or coding education push. Document your assumptions about shared technology and management time so you can repeat the same formula consistently next quarter.
Low-Cost vs High-Cost Revenue Cycle Management — What's the Difference?
A lower sticker price on RCM doesn't always mean lower total cost. The comparison that matters is net revenue after rework, write-offs, and missed charges.
Efficiency and Revenue Capture
A lower-cost model might run with fewer staff or smaller vendor fees. Before calling that efficient, check for missed charges, delayed claim submission, inaccurate payment posting, and thin A/R follow-up.
A higher-cost model often includes specialty-trained staff, pre-bill review, authorization tracking, and proactive A/R work. That spending only pays off if it demonstrably improves collections or cuts avoidable rework. Require the evidence; don't assume it.
Infectious Disease-Specific Risk
Compare how each model handles the moments where infectious disease billing actually breaks down:
- OPAT order documentation and reauthorization tracking
- Infusion start/stop time capture and hierarchy coding
- Drug and supply charge capture against administered-dose records
- Hospital-to-office transitions and discharge antimicrobial planning
- Coordination with outside infusion or home-health partners
The right workflow depends on your service mix, volume, and payer distribution, not a generic cheap-versus-expensive label.
Long-Term Value and Compliance
The strongest RCM model balances direct expense against clean-claim performance, timely reimbursement, audit readiness, and physician capacity. Cutting costs by skipping training, coding review, or authorization checks tends to show up later as denials, write-offs, or compliance exposure.
When evaluating an outside billing proposal, review:
- Percentage fee and any minimum monthly charge
- Setup or implementation costs
- Whether coding and authorization support are included
- Denial follow-up responsibilities
- Reporting access and transparency
- Termination terms
- Who handles payer enrollment and credentialing
Services like credentialing and payer enrollment or eligibility and authorization support are sometimes bundled into a billing contract and sometimes billed separately. Know which before you sign.
How to Estimate the Right Cost-to-Collect Target for an Infectious Disease Practice
There's no universal number to hit. The right target reflects your service-line complexity, compliance requirements, and how much financial visibility your leadership team actually needs.
A practical budgeting method:
- Define the numerator and denominator before pulling any data, and keep the definition fixed across periods
- Collect several reporting periods to smooth out one-off distortions
- Separate fixed and variable costs so you can model what changes with volume
- Segment by payer and service line — OPAT, infusion, hospital consults, and office visits rarely behave the same way
- Investigate anomalies, don't just react to a single bad month
Build a scorecard that reviews cost to collect alongside net collection rate, denial and appeal outcomes, clean-claim performance, days in A/R, aged A/R, underpayments, write-offs, authorization turnaround, and unresolved credit balances. One metric alone tells you almost nothing.
Before rolling out a change, better eligibility checks, infusion documentation templates, authorization tracking, a coding audit, measure both the incremental RCM expense and the resulting change in collectible revenue. Don't assume savings without your own practice data behind it.
If you want to model this with your own numbers, GrowInfectiousDisease's Independent ID Practice Economics Calculator and Infusion & OPAT Economics Calculator run in the browser, require no email, and let you test cost-to-collect scenarios without borrowing someone else's unverified benchmark.
What Most Practices Miss When It Comes to Cost to Collect
A few blind spots show up again and again:
- Counting only the vendor's fee or payroll line, while clearinghouse fees, technology costs, payment processing, management oversight, and rework stay invisible
- Using gross charges instead of actual collections as the denominator, which quietly distorts every comparison
- Treating all collections as one pool, instead of separating OPAT, infusion, hospital consult, and office performance
- Assuming a lower ratio means better performance, without checking for missed charges, aging A/R, delayed appeals, or underpayments sitting underneath it
- Relying on generalized reimbursement or margin figures instead of verifying current payer policy, place-of-service rules, and contract terms for your own practice
Hard-denial dollars on drug claims deserve particular attention here. In buy-and-bill, a denied infusion claim is a realized inventory loss, not deferred revenue you can collect later. That distinction alone changes how seriously a practice should treat its denial rate by dollars, not just by claim count.
Conclusion
Cost to collect is a measurement framework, not a fixed price. Its value depends on consistent definitions, complete expense capture, a clearly defined collections denominator, and comparable reporting periods.
For infectious disease practices, the useful question is whether your percentage reflects complete revenue capture, timely reimbursement, accurate OPAT and infusion billing, and a defensible compliance posture. Get those right, and the cost-to-collect number becomes a useful signal instead of a vanity metric.
Frequently Asked Questions
What are the billing guidelines for infusion services?
Billing depends on the infusion type, route, duration, administration sequence, place of service, and documentation supporting medical necessity. Accurate infusion billing directly affects cost to collect by reducing denials and rework.
What are the coding guidelines for infusion services?
Document the substance administered, route, start and stop times, administration sequence, and medical necessity. Apply the correct initial, subsequent, concurrent, or add-on code, then verify against current CPT and payer-specific guidance.
How to bill for IV hydration?
IV hydration coding depends on documented duration, initial versus add-on status, clinical purpose, and other services in the same encounter. Place of service and payer rules also determine which code applies.
Can you bill 96365 twice?
Repeating the initial infusion code generally requires a distinct encounter or a payer-recognized circumstance, such as a separate IV access site, not simply two infusions. Check NCCI edits, modifier requirements, and documentation before billing it twice.
How is home infusion billed?
Home infusion separates into drug, equipment, supplies, professional services, and nursing components, each with its own payer rules. CMS's home infusion guidance confirms that Medicare, commercial payers, and DME suppliers often require separate claims for these components.
How does Medicare pay for infusions?
Payment depends on the specific drug or service, Part B versus another benefit, place of service, and the applicable payment methodology. Check current CMS and Medicare Administrative Contractor guidance for coverage and coding rules.
